Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harvard Bioscience (HBIO) Assets Average (2016 - 2025)

Historic Assets Average for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to $79.0 million.

  • Harvard Bioscience's Assets Average fell 3923.34% to $79.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.0 million, marking a year-over-year decrease of 3923.34%. This contributed to the annual value of $132.0 million for FY2024, which is 661.98% down from last year.
  • According to the latest figures from Q3 2025, Harvard Bioscience's Assets Average is $79.0 million, which was down 3923.34% from $79.9 million recorded in Q2 2025.
  • In the past 5 years, Harvard Bioscience's Assets Average registered a high of $160.2 million during Q1 2022, and its lowest value of $79.0 million during Q3 2025.
  • Its 5-year average for Assets Average is $136.3 million, with a median of $144.2 million in 2023.
  • Per our database at Business Quant, Harvard Bioscience's Assets Average soared by 419.02% in 2022 and then plummeted by 3923.34% in 2025.
  • Quarter analysis of 5 years shows Harvard Bioscience's Assets Average stood at $158.1 million in 2021, then decreased by 7.54% to $146.2 million in 2022, then dropped by 5.22% to $138.6 million in 2023, then decreased by 6.94% to $128.9 million in 2024, then tumbled by 38.7% to $79.0 million in 2025.
  • Its Assets Average stands at $79.0 million for Q3 2025, versus $79.9 million for Q2 2025 and $103.2 million for Q1 2025.